Evidence map›Paper›PMID 21670398›Full record

Trial reportArchives of neurology2011

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

Jennifer L Bayer-Carter, Pattie S Green, Thomas J Montine, Brian VanFossen, Laura D Baker, G Stennis Watson, Laura M Bonner, Maureen Callaghan, James B Leverenz, Brooke K Walter and 8 more

Registry-linked trialAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Archives of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02474251 (Brain Sleep Clearance of Amyloid-Beta Peptides), which is not on this map. Cited by 81 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 4 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02474251 nacompletednot on this mapstarted 2015, after this paper: background citation

Brain Sleep Clearance of Amyloid-Beta Peptides

TypeinterventionalSponsorNYU Langone HealthRan2015 to 2019Enrolled38ConditionsObstructive Sleep Apnea, Alzheimer's DiseaseArmsContinuous positive airway pressure device
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 4 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Jennifer L Bayer-CarterGeriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108, USA.
Pattie S Green
Thomas J Montine
Brian VanFossen
Laura D Baker
G Stennis Watson
Laura M Bonner
Maureen Callaghan
James B Leverenz
Brooke K Walter
Elaine Tsai
Stephen R Plymate
Nadia Postupna
Charles W Wilkinson
Jing Zhang
Johanna Lampe
Steven E Kahn
Suzanne Craft
University of Washington · USFred Hutch Cancer Center · USVA Puget Sound Health Care System · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Glucose Regulation and Memory in Alzheimer's DiseaseR37AG010880 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE · 2005 to 2014
$5.2M
NEUROBEHAVIOR, NEUROENDOCRINOLOGY, AND GENETICS OF ADT32AG000258 · NIA · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 1999 to 2013
$4.7M
NIA NIH HHS 5T32 AG-000258NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG-05136NIA NIH HHS R37 AG010880NIA NIH HHS R37 AG-10880NIA NIH HHS T32 AG000258NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

objectiveTo compare the effects of a 4-week high-saturated fat/high-glycemic index (HIGH) diet with a low-saturated fat/low-glycemic index (LOW) diet on insulin and lipid metabolism, cerebrospinal fluid (CSF) markers of Alzheimer disease, and cognition for healthy adults and adults with amnestic mild cognitive impairment (aMCI).

designRandomized controlled trial.

settingVeterans Affairs Medical Center clinical research unit.

participantsForty-nine older adults (20 healthy adults with a mean [SD] age of 69.3 [7.4] years and 29 adults with aMCI with a mean [SD] age of 67.6 [6.8] years).

interventionParticipants received the HIGH diet (fat, 45% [saturated fat, > 25%]; carbohydrates, 35%-40% [glycemic index, > 70]; and protein, 15%-20%) or the LOW diet (fat, 25%; [saturated fat, < 7%]; carbohydrates, 55%-60% [glycemic index, < 55]; and protein, 15%-20%) for 4 weeks. Cognitive tests, an oral glucose tolerance test, and lumbar puncture were conducted at baseline and during the fourth week of the diet.

main outcome measuresThe CSF concentrations of β-amyloid (Aβ42 and Aβ40), tau protein, insulin, F2-isoprostanes, and apolipoprotein E, plasma lipids and insulin, and measures of cognition.

resultsFor the aMCI group, the LOW diet increased CSF Aβ42 concentrations, contrary to the pathologic pattern of lowered CSF Aβ42 typically observed in Alzheimer disease. The LOW diet had the opposite effect for healthy adults, ie, decreasing CSF Aβ42, whereas the HIGH diet increased CSF Aβ42. The CSF apolipoprotein E concentration was increased by the LOW diet and decreased by the HIGH diet for both groups. For the aMCI group, the CSF insulin concentration increased with the LOW diet, but the HIGH diet lowered the CSF insulin concentration for healthy adults. The HIGH diet increased and the LOW diet decreased plasma lipids, insulin, and CSF F2-isoprostane concentrations. Delayed visual memory improved for both groups after completion of 4 weeks of the LOW diet.

conclusionOur results suggest that diet may be a powerful environmental factor that modulates Alzheimer disease risk through its effects on central nervous system concentrations of Aβ42, lipoproteins, oxidative stress, and insulin.

Indexed as

AgedAlzheimer DiseaseAmnesiaAmyloid beta-PeptidesBiomarkersCognition DisordersDietary CarbohydratesDietary Fats, UnsaturatedFemaleFood, FormulatedHumansMaleMiddle AgedPeptide FragmentsSeverity of Illness IndexAmyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersDietary CarbohydratesDietary Fats, UnsaturatedPeptide Fragments

Identifiers

PMID21670398
PMCPMC3175115
OpenAlexW1973977721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.